Cummins Inc. (NYSE:CMI) today announced that its Filtration business has confidentially submitted a draft registration statement on Form S-1 with the U.S. Securities and Exchange Commission (the "SEC") for a
Key takeaways:
Vaccine maker AIM has filed for an IPO in Hong Kong, following unsuccessful previous bids in Hong Kong and on Shenzhen’s ChiNext board
The company has three Covid vaccines under development, including an mRNA vaccine expected to hit the market in the fourth quarter
By Fai Pui
Cybersecurity has been top of mind for most companies and governments in recent years as ransomware attacks, phishing attacks and denial-of-service (DOS) attacks have increased.
Key takeaways:
Zhihu will make a second primary listing in Hong Kong alongside its current U.S. listing, aiming to ease U.S. regulatory pressure and reach more Chinese investors
Lukewarm interest in the new Hong Kong offering suggests investors are concerned about the company’s growing losses
By Jony Ho
Key takeaways:
METiS Pharmaceuticals has completed five funding rounds since its establishment in January 2020, including the latest two worth $150 million
The company was incubated by AI pharmaceutical unicorn XtaiPl, whose most recent valuation exceeded $2.05 billion
By Molly Wen